Concepedia

Sue Sha

SS

15

Publications

1.7K

Citations

15

H-Index

1989

Active since

Affiliations

Janssen (United States)(Current)

Profil Institute for Metabolic Research

Janssen (Belgium)

University of California San Diego

Johnson & Johnson (United States)

Sue Sha is an author at Janssen (United States) specializing in medicine, pharmacology, and drug safety.

Top concepts

Publications per year

1989–2018

15

Publications

15

Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

Sue Sha, Damayanthi Devineni, A. Ghosh et al. · Diabetes Obesity and Metabolism · 2011 · 292 citations

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion

David Polidori, Sue Sha, Sunder Mudaliar et al. · Diabetes Care · 2013 · 259 citations · Full text

Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus

Sue Sha, David Polidori, Tim Heise et al. · Diabetes Obesity and Metabolism · 2014 · 235 citations

Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes

Kenneth Cusi, Fernando Bril, Diana Barb et al. · Diabetes Obesity and Metabolism · 2018 · 191 citations

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin

Klaus Rave, S. Bott, Lutz Heinemann et al. · Diabetes Care · 2005 · 171 citations · Full text

Rows per page

1–5 of 15